SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.62+0.1%Dec 24 12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: celeryroot.com who wrote (22471)6/18/1998 3:02:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
I did get through to LGND IR today and they still consider ONTAK "on track" with a 3Q approval and a 4Q launch anticipated. The "deficiencies" are well known to SRGN and they have been in talks with the FDA for some time. The announcement last night was due to the six month expiration date and a similar situation happened with IDPH (and their drug was approved after the deficiencies were removed). The new 6 month rule went into effect "about 9 months ago" according to LGND IR.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext